MARK W. REYNOLDS
Profile
First Name
: MARK
Middle Name
: W.
Last Name
: REYNOLDS
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
STEVEN ANTEBI, RANDAL D. CHASE, DAVID DODD, DAVID A DODD, DAVID A. DODD, FARSHAD GUIRAKHOO, DONALD HILDEBRAND, DEAN KOLLINTZAS, DEAN G KOLLINTZAS, DEAN G. KOLLINTZAS, ROBERT MCNALLY, ROBERT T MCNALLY, ROBERT T. MCNALLY, MARK J. NEWMAN, MARK REYNOLDS, MARK W REYNOLDS, HARRIET ROBINSON, HARRIET L ROBINSON, HARRIET L. ROBINSON, JOHN SPENCER, JOHN N. SPENCER, JOHN N. SPENCER, JR., PETER TSOLINAS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-05-25
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-01-19
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-02-11
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-09-29
D
BIOTECHNOLOGY
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Debt
2020-06-26
D/A
BIOTECHNOLOGY
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2019-07-16
D
BIOTECHNOLOGY
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2019-07-24
D/A
BIOTECHNOLOGY
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2019-07-24
